← 產業報告目錄
Sterile Injection Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 124報告編號 APO-eb10cc776f
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Sterile Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Sterile Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Sterile Injection market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Sterile Injection market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Sterile Injection include Gilead Sciences, Johnson & Johnson Merck & Co., Novo Nordisk A/S, Amgen, Baxter International, GlaxoSmithKline, Pfizer, Merck & Co., Inc. and Novartis AG and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sterile Injection market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Sterile Injection.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sterile Injection Market by Company
Gilead Sciences
Johnson & Johnson Merck & Co.
Novo Nordisk A/S
Amgen
Baxter International
GlaxoSmithKline
Pfizer
Merck & Co., Inc.
Novartis AG
Sanofi
Sterile Injection Segment by Type
Monoclonal Antibodies
Immunoglobulin
Cytokines
Blood Factors
Insulin
Other
Sterile Injection Segment by Application
Infectious Disease
Diabetes
Cardiovascular Diseases
Tumor
Other
Sterile Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sterile Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Sterile Injection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Sterile Injection by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Monoclonal Antibodies
2.2.3 Immunoglobulin
2.2.4 Cytokines
2.2.5 Blood Factors
2.2.6 Insulin
2.2.7 Other
2.3 Sterile Injection by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Infectious Disease
2.3.3 Diabetes
2.3.4 Cardiovascular Diseases
2.3.5 Tumor
2.3.6 Other
2.4 Assumptions and Limitations
3 Sterile Injection Breakdown Data by Type
3.1 Global Sterile Injection Historic Market Size by Type (2021-2026)
3.2 Global Sterile Injection Forecasted Market Size by Type (2027-2032)
4 Sterile Injection Breakdown Data by Application
4.1 Global Sterile Injection Historic Market Size by Application (2021-2026)
4.2 Global Sterile Injection Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Sterile Injection Market Perspective (2021-2032)
5.2 Global Sterile Injection Growth Trends by Region
5.2.1 Global Sterile Injection Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Sterile Injection Historic Market Size by Region (2021-2026)
5.2.3 Sterile Injection Forecasted Market Size by Region (2027-2032)
5.3 Sterile Injection Market Dynamics
5.3.1 Sterile Injection Industry Trends
5.3.2 Sterile Injection Market Drivers
5.3.3 Sterile Injection Market Challenges
5.3.4 Sterile Injection Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Sterile Injection Players by Revenue
6.1.1 Global Top Sterile Injection Players by Revenue (2021-2026)
6.1.2 Global Sterile Injection Revenue Market Share by Players (2021-2026)
6.2 Global Sterile Injection Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Sterile Injection Head Office and Area Served
6.4 Global Sterile Injection Players, Product Type & Application
6.5 Global Sterile Injection Manufacturers Established Date
6.6 Global Sterile Injection Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Sterile Injection Market Size (2021-2032)
7.2 North America Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Sterile Injection Market Size by Country (2021-2026)
7.4 North America Sterile Injection Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Sterile Injection Market Size (2021-2032)
8.2 Europe Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Sterile Injection Market Size by Country (2021-2026)
8.4 Europe Sterile Injection Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Sterile Injection Market Size (2021-2032)
9.2 Asia-Pacific Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Sterile Injection Market Size by Country (2021-2026)
9.4 Asia-Pacific Sterile Injection Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Sterile Injection Market Size (2021-2032)
10.2 South America Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Sterile Injection Market Size by Country (2021-2026)
10.4 South America Sterile Injection Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Sterile Injection Market Size (2021-2032)
11.2 Middle East & Africa Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Sterile Injection Market Size by Country (2021-2026)
11.4 Middle East & Africa Sterile Injection Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Gilead Sciences
12.1.1 Gilead Sciences Company Information
12.1.2 Gilead Sciences Business Overview
12.1.3 Gilead Sciences Revenue in Sterile Injection Business (2021-2026)
12.1.4 Gilead Sciences Sterile Injection Product Portfolio
12.1.5 Gilead Sciences Recent Developments
12.2 Johnson & Johnson Merck & Co.
12.2.1 Johnson & Johnson Merck & Co. Company Information
12.2.2 Johnson & Johnson Merck & Co. Business Overview
12.2.3 Johnson & Johnson Merck & Co. Revenue in Sterile Injection Business (2021-2026)
12.2.4 Johnson & Johnson Merck & Co. Sterile Injection Product Portfolio
12.2.5 Johnson & Johnson Merck & Co. Recent Developments
12.3 Novo Nordisk A/S
12.3.1 Novo Nordisk A/S Company Information
12.3.2 Novo Nordisk A/S Business Overview
12.3.3 Novo Nordisk A/S Revenue in Sterile Injection Business (2021-2026)
12.3.4 Novo Nordisk A/S Sterile Injection Product Portfolio
12.3.5 Novo Nordisk A/S Recent Developments
12.4 Amgen
12.4.1 Amgen Company Information
12.4.2 Amgen Business Overview
12.4.3 Amgen Revenue in Sterile Injection Business (2021-2026)
12.4.4 Amgen Sterile Injection Product Portfolio
12.4.5 Amgen Recent Developments
12.5 Baxter International
12.5.1 Baxter International Company Information
12.5.2 Baxter International Business Overview
12.5.3 Baxter International Revenue in Sterile Injection Business (2021-2026)
12.5.4 Baxter International Sterile Injection Product Portfolio
12.5.5 Baxter International Recent Developments
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Information
12.6.2 GlaxoSmithKline Business Overview
12.6.3 GlaxoSmithKline Revenue in Sterile Injection Business (2021-2026)
12.6.4 GlaxoSmithKline Sterile Injection Product Portfolio
12.6.5 GlaxoSmithKline Recent Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Revenue in Sterile Injection Business (2021-2026)
12.7.4 Pfizer Sterile Injection Product Portfolio
12.7.5 Pfizer Recent Developments
12.8 Merck & Co., Inc.
12.8.1 Merck & Co., Inc. Company Information
12.8.2 Merck & Co., Inc. Business Overview
12.8.3 Merck & Co., Inc. Revenue in Sterile Injection Business (2021-2026)
12.8.4 Merck & Co., Inc. Sterile Injection Product Portfolio
12.8.5 Merck & Co., Inc. Recent Developments
12.9 Novartis AG
12.9.1 Novartis AG Company Information
12.9.2 Novartis AG Business Overview
12.9.3 Novartis AG Revenue in Sterile Injection Business (2021-2026)
12.9.4 Novartis AG Sterile Injection Product Portfolio
12.9.5 Novartis AG Recent Developments
12.10 Sanofi
12.10.1 Sanofi Company Information
12.10.2 Sanofi Business Overview
12.10.3 Sanofi Revenue in Sterile Injection Business (2021-2026)
12.10.4 Sanofi Sterile Injection Product Portfolio
12.10.5 Sanofi Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Sterile Injection Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Sterile Injection Revenue Market Share by Type (2021-2026)
Table 7. Global Sterile Injection Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Sterile Injection Revenue Market Share by Type (2027-2032)
Table 9. Global Sterile Injection Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Sterile Injection Revenue Market Share by Application (2021-2026)
Table 11. Global Sterile Injection Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Sterile Injection Revenue Market Share by Application (2027-2032)
Table 13. Global Sterile Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Sterile Injection Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Sterile Injection Market Share by Region (2021-2026)
Table 16. Global Sterile Injection Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Sterile Injection Market Share by Region (2027-2032)
Table 18. Sterile Injection Industry Trends
Table 19. Sterile Injection Industry Drivers
Table 20. Sterile Injection Industry Opportunities and Challenges
Table 21. Sterile Injection Market Restraints
Table 22. Global Top Sterile Injection Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Sterile Injection Revenue Market Share by Players (2021-2026)
Table 24. Global Sterile Injection Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Sterile Injection, Headquarters and Area Served
Table 26. Global Sterile Injection Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Sterile Injection by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Sterile Injection Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Sterile Injection Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Sterile Injection Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Sterile Injection Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Sterile Injection Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Sterile Injection Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Sterile Injection Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Sterile Injection Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Sterile Injection Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Sterile Injection Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Sterile Injection Market Size by Country (2027-2032) & (US$ Million)
Table 45. Gilead Sciences Company Information
Table 46. Gilead Sciences Business Overview
Table 47. Gilead Sciences Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 48. Gilead Sciences Sterile Injection Product Portfolio
Table 49. Gilead Sciences Recent Developments
Table 50. Johnson & Johnson Merck & Co. Company Information
Table 51. Johnson & Johnson Merck & Co. Business Overview
Table 52. Johnson & Johnson Merck & Co. Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 53. Johnson & Johnson Merck & Co. Sterile Injection Product Portfolio
Table 54. Johnson & Johnson Merck & Co. Recent Developments
Table 55. Novo Nordisk A/S Company Information
Table 56. Novo Nordisk A/S Business Overview
Table 57. Novo Nordisk A/S Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 58. Novo Nordisk A/S Sterile Injection Product Portfolio
Table 59. Novo Nordisk A/S Recent Developments
Table 60. Amgen Company Information
Table 61. Amgen Business Overview
Table 62. Amgen Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 63. Amgen Sterile Injection Product Portfolio
Table 64. Amgen Recent Developments
Table 65. Baxter International Company Information
Table 66. Baxter International Business Overview
Table 67. Baxter International Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 68. Baxter International Sterile Injection Product Portfolio
Table 69. Baxter International Recent Developments
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 73. GlaxoSmithKline Sterile Injection Product Portfolio
Table 74. GlaxoSmithKline Recent Developments
Table 75. Pfizer Company Information
Table 76. Pfizer Business Overview
Table 77. Pfizer Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 78. Pfizer Sterile Injection Product Portfolio
Table 79. Pfizer Recent Developments
Table 80. Merck & Co., Inc. Company Information
Table 81. Merck & Co., Inc. Business Overview
Table 82. Merck & Co., Inc. Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 83. Merck & Co., Inc. Sterile Injection Product Portfolio
Table 84. Merck & Co., Inc. Recent Developments
Table 85. Novartis AG Company Information
Table 86. Novartis AG Business Overview
Table 87. Novartis AG Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 88. Novartis AG Sterile Injection Product Portfolio
Table 89. Novartis AG Recent Developments
Table 90. Sanofi Company Information
Table 91. Sanofi Business Overview
Table 92. Sanofi Revenue in Sterile Injection Business (2021-2026) & (US$ Million)
Table 93. Sanofi Sterile Injection Product Portfolio
Table 94. Sanofi Recent Developments
Table 95. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Sterile Injection Product Image
Figure 5. Global Sterile Injection Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Sterile Injection Market Share by Type: 2025 VS 2032
Figure 7. Monoclonal Antibodies Product
Figure 8. Immunoglobulin Product
Figure 9. Cytokines Product
Figure 10. Blood Factors Product
Figure 11. Insulin Product
Figure 12. Other Product
Figure 13. Global Sterile Injection Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 14. Global Sterile Injection Market Share by Application: 2025 VS 2032
Figure 15. Infectious Disease Product
Figure 16. Diabetes Product
Figure 17. Cardiovascular Diseases Product
Figure 18. Tumor Product
Figure 19. Other Product
Figure 20. Global Sterile Injection Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 21. Global Sterile Injection Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 22. Global Sterile Injection Market Share by Region: 2025 VS 2032
Figure 23. Global Sterile Injection Market Share by Players in 2025
Figure 24. Global Sterile Injection Manufacturers Established Date
Figure 25. Global Top 5 and 10 Sterile Injection Players Market Share by Revenue in 2025
Figure 26. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 27. North America Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. North America Sterile Injection Market Share by Country (2021-2032)
Figure 29. United States Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Canada Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Mexico Sterile Injection Market Share by Country (2021-2032)
Figure 32. Europe Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Europe Sterile Injection Market Share by Country (2021-2032)
Figure 34. Germany Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. France Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. U.K. Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Italy Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Spain Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Russia Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Netherlands Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Nordic Countries Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Asia-Pacific Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. Asia-Pacific Sterile Injection Market Share by Country (2021-2032)
Figure 44. China Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. Japan Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. South Korea Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. India Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. India Sterile Injection Market Share by Country (2021-2032)
Figure 49. Australia Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. China Taiwan Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. South America Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. South America Sterile Injection Market Share by Country (2021-2032)
Figure 54. Brazil Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Argentina Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Chile Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 57. Colombia Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 58. Peru Sterile Injection Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 59. Gilead Sciences Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 60. Johnson & Johnson Merck & Co. Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 61. Novo Nordisk A/S Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 62. Amgen Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 63. Baxter International Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 65. Pfizer Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 66. Merck & Co., Inc. Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 67. Novartis AG Revenue Growth Rate in Sterile Injection Business (2021-2026)
Figure 68. Sanofi Revenue Growth Rate in Sterile Injection Business (2021-2026)
提及公司
Gilead SciencesJohnson & Johnson Merck & Co.Novo Nordisk A/SAmgenBaxter InternationalGlaxoSmithKlinePfizerMerck & Co., Inc.Novartis AGSanofi
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們